National Institutes of Health
NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) is a funding opportunity from National Institutes of Health, closing November 16, 2029.
Overview
The purpose of NEI's Translational Research program (TRP) is the rapid and efficient translation of innovative laboratory research findings into therapeutics for use by clinicians to treat visual system diseases or disorders. The TRP will support the product development of biological, pharmaceutical, medical device,…